POORLY DIFFERENTIATED THYROID CARCINOMA

POORLY DIFFERENTIATED THYROID CARCINOMA was reported 10 times

These drugs are most commonly taken by patients reporting POORLY DIFFERENTIATED THYROID CARCINOMA:

# Drug Count
0 SORAFENIB 6
1 DENOSUMAB 2
2 LENVATINIB 2
3 PACLITAXEL 2
4 PACLITAXEL (AIBUMIN-BOUND) 2
5 PAZOPANIB 2
6 PAZOPANIB HYDROCHLORIDE 2
7 PEMBROLIZUMAB 2
8 PEMETREXED 2
9 PEMETREXED DISODIUM 2
10 CERITINIB 1
11 EMPAGLIFLOZIN 1
12 ESOMEPRAZOLE 1
13 ESOMEPRAZOLE MAGNESIUM 1
14 FREMANEZUMAB-VFRM 1
15 LITHIUM CARBONATE 1
16 METFORMIN 1
17 METFORMIN ER 500 MG 1
18 METFORMIN ER 750 MG 1
19 ORAL SEMAGLUTIDE 1
20 VALACYCLOVIR 1
21 VALACYCLOVIR HYDROCHLORIDE 1